Scandinavian Journal of Gastroenterology · 1992 · 22 citations · 19 references
PharmacyInternal MedicinePharmacotherapyHepatic PharmacotherapyHepatologyMucosal Drug DeliveryBiliary Tract DiseaseBiliary Tract DisordersCholestatic Liver Disease TherapyHepatic PerfusionJaundice ManagementLiver DiseaseCholestatic JaundicePruritus In Liver DiseaseSymptomatic Management Of CholestasisSymptomatic PresentationSymptomatic TherapyTreatment Periods
The efficacy of plasma perfusion through a new anionic resin, BR-350, for palliation of intractable pruritus secondary to intrahepatic cholestasis was studied in four patients. The treatment was given in a daily 2-h session on 3 consecutive days and was followed by repeated treatment periods each 3rd to 4th week. The patients experienced symptomatic improvement during the first treatment period, and the treatment was well tolerated. Adsorption of bile acids across the filter was efficient and resulted in a bile acid concentration gradient pre- to post-resin of 92%. Thus plasma perfusion through the ion resin BR-350 is an effective and safe treatment for symptomatic relief of intractable pruritus in cholestatic liver disease and may reduce hospitalization time and increase the quality of life.
19
New conceptions in the pathogenesis of sciatic pain
The American Journal of Surgery · 1927 · 580 citations
Sulphated and unsulphated bile acids in serum, bile, and urine of patients with cholestasis.
G. P. van Berge Henegouwen, K H Brandt, H. Eyssen et al. · Gut · 1976 · 174 citations · Full text